Expert Opinion on Emerging Drugs
Q2 Journal
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Pharmacology
Q2
└
Pharmacology (medical)
Q2
Publisher
SJR 2025
0.908
Q2
SJR Score
H-Index
59
Citations / Doc (2yr)
3.44
Total Docs. (latest)
22
Total Citations (3yr)
308
Publication type
Journals
ISSN
14728214, 17447623
Coverage
2000-2025
Journal Rank
#5,701
Subject Categories
Pharmacology
Q2
Pharmacology (medical)
Q2
Subject Areas
Aims & Scope
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 22 |
| Total Docs. (3 years) | 96 |
| Total Refs. | 1,674 |
| Total Citations (3 years) | 308 |
| Citable Docs. (3 years) | 83 |
| Citations / Doc. (2 years) | 3.44 |
| Ref. / Doc. | 76.09 |
| % Female | 54.7% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.